Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://www.ncbi.nlm.nih.gov/pubmed/27525431
http://dx.doi.org/10.1007/s11011-016-9882-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://www.ncbi.nlm.nih.gov/pubmed/27525431
http://dx.doi.org/10.1007/s11011-016-9882-2

Ejemplares similares